| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |